MAYNF (Mayne Pharma Group) Book Value per Share : $3.71 (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mayne Pharma Group Book Value per Share?

Mayne Pharma Group's book value per share for the quarter that ended in Jun. 2024 was $3.71.

During the past 12 months, Mayne Pharma Group's average Book Value Per Share Growth Rate was -26.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -13.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Mayne Pharma Group was 51.10% per year. The lowest was -20.50% per year. And the median was 12.30% per year.

Mayne Pharma Group's current price is $2.61. Its book value per share for the quarter that ended in Jun. 2024 was $3.71. Hence, today's PB Ratio of Mayne Pharma Group is 0.70.

During the past 13 years, the highest P/B Ratio of Mayne Pharma Group was 4.68. The lowest was 0.38. And the median was 0.82.

Mayne Pharma Group Book Value per Share Historical Data

The historical data trend for Mayne Pharma Group's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Book Value per Share Chart

Mayne Pharma Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Book Value per Share

Get a 7-Day Free Trial

8.53

6.66

4.50

5.10

3.71

Mayne Pharma Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Book Value per Share	Get a 7-Day Free Trial															4.50	6.10	5.10	4.51	3.71

Competitive Comparison of Mayne Pharma Group's Book Value per Share

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's PB Ratio falls into.

Mayne Pharma Group Book Value per Share Calculation

Mayne Pharma Group's Book Value Per Share for the fiscal year that ended in Jun. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(301.6	-	0.0)	/	81.2
	=	3.71

Mayne Pharma Group's Book Value Per Share for the quarter that ended in Jun. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(301.6	-	0.0)	/	81.2
	=	3.71

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Mayne Pharma Group (OTCPK:MAYNF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Mayne Pharma Group Book Value per Share Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MAYNF) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

HG6:Germany MYX:Australia

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.